Helicobacter pylori May Cause "Reflux" Gastritis after Gastrectomy

Journal of Gastrointestinal Surgery

Volumn 1, Issue 5, 1997, Pages 479-486

  Nagahata, Yoshi ^a   Azumi, Yasutomo ^a   Numata, Norihisa ^a   Yano, Masafumi ^a   Akimoto, Teruyuki ^a   Saitoh, Yoichi ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0347936197     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(97)80137-0     Document Type: Article

References (37)

1. Van Heerden JA, Phillips SF, Adson MA, Mcllrath DC. Postoperative reflux gastritis. Am J Surg 1975;129:82-88.
2. Nath BJ, Warshaw AL. Alkaline reflux gastritis and esophagitis. Ann Rev Med 1984;35:383-396.
3. Ritchie WP. Alkaline reflux gastritis: A critical reappraisal. Gut 1984;25:975-987.
4. Burden WR, Hodges RP, Hsu M, O'Leary JP. Alkaline reflux gastritis. Surg Clin North Am 1991;71:33-44.
5. Roberts JW, Hardin WJ. Postoperative bile gastritis. Surg Clin North Am 1979;59:781-786.
6. Warren JR, Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;1:1273-1275.
7. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984;1:1311-1315.
8. Cutler AF, Schubert TT. Long-term Helicobacter pylori recurrence after successful eradication with triple therapy. Am J Gastroenterol 1993;88:1359-1361.
9. Bell GD, Powell KU. Eradication of Helicobacter pylori and its effect in peptic ulcer disease. Scand J Gastroenterol 1993;28:7-11.
10. Lanza FL, Skoglund ML, Rack MF, YardleyJH. The effect of bismuth subsalicylate on the histologic gastritis seen with Campylobacter pylori: A placebo-controlled, randomized study. Am J Gastroenterol 1989;84:1060-1064.
11. McNulty CAM, Watson DM. Spiral bacteria of the gastric antrum. Lancet 1984;1:1068-1069.
12. Tytgat GNJ. The Sydney system: Endoscopic division. Endoscopic appearances in gastritis/duodenitis. J Gastroenterol Hepatol 1991;6:223-234.
13. Rauws EA, Langenberg W, Houthoff HJ, Zanen HC, Tytgat GNJ. Campylobacter pyloridis-associated chronic active gastritis: A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 1988;94:33-40.
14. Andreica V, Suciu A, Dumitrascu D, Draghici A, Pascu O, Suciu M, Ban A. Biochemical changes induced by Campylobacter pylori in the gastric juice. Rev Roum Med Int 1990; 28:145-152.
15. Blaser MJ. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis 1990; 161:626-633.
16. Hansson LE, Engstrand L, Nyren O, Evans DJ, Lindgren A, Bergstrom R, Andersson B, Athlin L, Bendsten O, Tracz P. Helicobacter pylori infection: Independent risk indicator of gastric adenocarcinoma. Gastroenterology 1993;105:1098-1103.
17. Sipponen P, Seppala K. Gastric carcinoma: Failed adaptation to Helicobacter pylori. Scand J Gastroenterol 1992;27:33-38.
18. Nomura A, Stemmermann GN. Helicobacter pylori and gastric cancer. J Gastroenterol Hepatol 1993;8:294-303.
19. Wlodarczyk A, Bielecki K, Talalaj M, Marcinowska-Suchowierska E, Zawadzki J, Ciok M, Gajda A, Brzozowski R. Long-term consequences of surgical treatment of peptic ulcer. Mater Med Pol 1994;26:13-16.
20. 13C-urea breath test - Detection of Helicobacter pylori infection in patients with partial gastrectomy. Z Gastroenterol 1993;31:115-119.
21. Wirth HP, Scheiwiller A, Flury R, Casanova C, Muller A, Hoffmann R, Ammann R, Altorfer J. Helicobacter pylori colonization of the gastric remnant following partial resection. Schweiz Med Wochenschr 1992;122:1015-1018.
22. Siurala M, Sipponen P, Kekki M. Campylobacter pylori in a sample of Finnish population: Relations to morphology and functions of the gastric mucosa. Gut 1988;29:909-915.
23. Mossi S, Meyer-Wyss B, Renner EL, Merki HS, Gamboni G, Beglinger C. Influence of Helicobacter pylori, sex, and age on serum gastrin and pepsinogen concentrations in subjects without symptoms and patients with duodenal ulcers. Gut 1993;34:752-756.
24. Graham DY, Malaty HM, Evans DG, Evans DJ, Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Gastroenterology 1991;100:1495-1501.
25. Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazaki T, Miki K, Graham DY. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 1992;102:760-766.
26. Mortensen NJM, Thomas WEG, Jones SM, Savage A. Endoscopic screening for premalignant changes 25 years after gastrectomy: Results of a five-year prospective study. Br J Surg 1984;71:363-367.
27. Savage A, Jones S. Histological appearances of the gastric mucosa 15-27 years after partial gastrectomy. J Clin Pathol 1979;32:179-186.
28. O'Connor HJ, Dixon MF, Wyatt JI, Axon ATR, Ward DC, Dewar EP, Johnston D. Effect of duodenal ulcer surgery and enterogastric reflux on Campylobacter pyloridis. Lancet 1986;2:1178-1181.
29. Moss S, Calam J. Helicobacter pylori and peptic ulcers: The present position. Gut 1992;33:289-292.
30. Moss S, Legon S, Bishop AE, Calam J. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 1992;340:930-932.
31. Fung WP, Papadimitriou JM, Matz LR. Endoscopic, histological and ultrastructural correlations in chronic gastritis. Am J Gastroenterol 1979;71:269-279.
32. Toukan AU, Kamal MF, Amr SS, Arnaout MA, Abu-Romiyeh AS. Gastroduodenal inflammation in patients with nonulcer dyspepsia: A controlled endoscopic and morphometric study. Dig Dis Sci 1985;30:313-320.
33. Lawson HH. The reversibility of postgastrectomy alkaline reflux gastritis by a Roux-en-Y loop. Br J Surg 1972;59:13-15.
34. Chiba N, Rao BV, Rademaker JW, Hunt RH. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol 1992;87:1716-1727.
35. Sunairi M, Watanabe K, Suzuki T, Takana N, Kuwatama H, Nakajima M. Effects of anti-ulcer agents on antibiotic activity against Helicobacter pylori. Eur J Gastroenterol Hepatol 1994;6(Suppl 1):S121-S124.
36. McNulty CAM. Bacteriological and pharmacological basis for the treatment of Campylobacter pylori infection. In Rothbone BJ, Heady RV, eds. Campylobacter Pylori and Gastroduodenal Disease. Oxford: Blackwell Scientific Publications, 1989, pp 209-216.
37. McNulty CAM, Gearty JC, Crump B, Davis M, Donovan IA, Melikian V, Lister DM, Wise R. Campylobacter pyloridis and associated gastritis: Investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate. Br Med J 1986;293:645-649.